Effects of Hyperbaric Oxygen Preconditioning on Doxorubicin Cardiorespiratory Toxicity

• Autors principals: Vivian Doerr (Autor), Ryan N. Montalvo (Autor), Branden L. Nguyen (Autor), Franccesco P. Boeno (Autor), Michael D. Sunshine (Autor), Victoria E. Bindi (Autor), David D. Fuller (Autor), Ashley J. Smuder (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2022-10-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Cardiorespiratory dysfunction resulting from doxorubicin (DOX) chemotherapy treatment is a debilitating condition affecting cancer patient outcomes and quality of life. DOX treatment promotes cardiac and respiratory muscle pathology due to enhanced reactive oxygen species (ROS) production, mitochond...